ANALYSIS OF METABOLISM IN MULTIPLE SCLEROSIS PATIENTS

被引：0
|
作者：
NEU, I [1 ]
机构：
[1] UNIV MUNICH,KLINIKUM GROSSHADERN,MED KLIN & POLIKLIN,D-8000 MUNICH 70,FED REP GER
来源：
FORTSCHRITTE DER MEDIZIN | 1979年 / 97卷 / 27期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1211 / 1211
页数：1
相关论文
共 50 条
  • [21] Analysis of respiratory function in patients with multiple sclerosis
    Del Corral Nunez-Flores, Tamara
    Aguilar Zafra, Sandra
    De Gabriel Hierro, Almudena
    Montero Gonzalez, Noelia
    De Uralde Villanueva, Ibai Lopez
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [22] Analysis of treatment changes for patients with multiple sclerosis
    Balbona-Bayona, Mireya
    Redondo-Capafons, Susana
    Garriga-Biosca, Rosa
    Modamio, Pilar
    Marino, Eduardo L.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2017, 39 (01) : 268 - 268
  • [23] Serum iron metabolism markers including hepcidin in multiple sclerosis patients
    Hamit yasar Ellidag
    Fatma Kurtulus
    Aylin Yaman
    Esin Eren
    Necat Yılmaz
    Ozgur Aydin
    Aslı Bayındır
    Neurochemical Journal, 2014, 8 : 226 - 230
  • [24] Baseline cerebral metabolism predicts fatigue and cognition in Multiple Sclerosis patients
    West, Kl
    Sivakolundu, Dk
    Maruthy, Gb
    Zuppichini, Md
    Liu, P.
    Thomas, Bp
    Spence, Js
    Lu, H.
    Okuda, Dt
    Rypma, B.
    NEUROIMAGE-CLINICAL, 2020, 27
  • [25] Baseline Cerebral Metabolism Predicts Fatigue And Cognition In Multiple Sclerosis Patients
    West, K. L.
    Sivakolundu, D. K.
    Maruthy, G. B.
    Zuppichini, M. D.
    Lu, P.
    Thomas, B.
    Lu, H.
    Okuda, D. T.
    Rypma, B.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (1_SUPPL) : 6 - 7
  • [26] Serum iron metabolism markers including hepcidin in multiple sclerosis patients
    Ellidag, Hamit Yasar
    Kurtulus, Fatma
    Yaman, Aylin
    Eren, Esin
    Yilmaz, Necat
    Aydin, Ozgur
    Bayindir, Asli
    NEUROCHEMICAL JOURNAL, 2014, 8 (03) : 226 - 230
  • [27] Potential Factors Influencing Vitamin D Metabolism in Multiple Sclerosis Patients
    Burton, Jodie M.
    NEUROLOGY, 2010, 74 (09) : A157 - A157
  • [28] Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients With Relapsing and Primary Progressive Multiple Sclerosis
    Hauser, Stephen L.
    Kappos, Ludwig
    Montalban, Xavier
    Hughes, Richard
    McNamara, John
    Pradhan, Ashish
    Wormser, David
    Koendgen, Harold
    Wolinsky, Jerry S.
    NEUROLOGY, 2019, 92 (15)
  • [29] Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis
    Hauser, S. L.
    Kappos, L.
    Montalban, X.
    Hughes, R.
    Koendgen, H.
    McNamara, J.
    Pradhan, A.
    Wormser, D.
    Wolinsky, J. S.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 697 - 698
  • [30] Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis
    Hauser, S. L.
    Kappos, L.
    Montalban, X.
    Chognot, C.
    Jessop, N.
    Pradhan, A.
    Prajapati, K.
    Wolinsky, J. S.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 607 - 608
12345